A ASTRIA THERAPEUTICS
Live / Applied — Third extension granted (statement of use) (as of 28 Oct 2025)
What this means for you
Not registered yet, but its 19 Jul 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90835418
- Mark type
- Design + words
- Filed
- 19 Jul 2021
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Richard Todd Armstrong
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of allergic and inflammatory diseases and disorders; all of the foregoing do not contain cannabis, hemp, or derivatives thereof
Owner
- ASTRIA THERAPEUTICS, INC., Boston, MA, US
- ASTRIA THERAPEUTICS, INC., Boston, MA, US
- Catabasis Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 29 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Oct 2025 — SOU EXTENSION 3 GRANTED
- 28 Oct 2025 — SOU EXTENSION 3 FILED
- 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2025 — SOU EXTENSION 2 GRANTED
- 02 May 2025 — SOU EXTENSION 2 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2024 — SOU EXTENSION 1 GRANTED
- 22 Oct 2024 — SOU EXTENSION 1 FILED
- 22 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED